Development of an automated closed system for generation of human lymphokine-activated killer (LAK) cells for use in adoptive immunotherapy
- 1 August 1987
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 101 (2), 171-181
- https://doi.org/10.1016/0022-1759(87)90148-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Large scale production of human lymphokine activated killer cells for use in adoptive immunotherapyJournal of Immunological Methods, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo.The Journal of Immunology, 1985
- An enzymatic method for the consistent production of monodispersed viable cell suspensions from human solid tumorsJournal of Surgical Oncology, 1985
- SUCCESSFUL IMMUNOTHERAPY OF MURINE EXPERIMENTAL HEPATIC METASTASES WITH LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-21985
- Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2Science, 1984
- Biological Activity of Recombinant Human Interleukin-2 Produced in Escherichia coliScience, 1984
- LYSIS OF FRESH HUMAN SOLID TUMORS BY AUTOLOGOUS LYMPHOCYTES ACTIVATED INVITRO WITH LECTINS1982